Literature DB >> 8500280

Putative mechanisms of the effect of intravenous gamma-globulin.

F S Rosen1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8500280     DOI： 10.1006/clin.1993.1082

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  8 in total

1.  Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance.

Authors:  Chiharu Kishimoto; Keisuke Shioji; Tetsuo Hashimoto; Hiroshi Nonogi; Jong-Dae Lee; Shigeru Kato; Shinya Hiramitsu; Shin-ihiro Morimoto
Journal:  Heart Vessels       Date:  2013-05-24       Impact factor: 2.037

Review 2.  Immunity, infection, and nasal disease.

Authors:  S H Yoshida; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  1998 Spring-Summer       Impact factor: 8.667

3.  Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease.

Authors:  H Suzuki; S Uemura; S Tone; T Iizuka; M Koike; K Hirayama; J Maeda
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

Review 4.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

5.  Intravenous immunoglobulin prevents experimental autoimmune myositis in SJL mice by reducing anti-myosin antibody and by blocking complement deposition.

Authors:  J Wada; N Shintani; K Kikutani; T Nakae; T Yamauchi; K Takechi
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

Review 6.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

7.  Successful high-dose intravenous immunoglobulin therapy for a patient with fulminant myocarditis.

Authors:  Shigeru Kato; Shin-ichiro Morimoto; Shinya Hiramitsu; Akihisa Uemura; Masatsugu Ohtsuki; Yasuchika Kato; Kenji Miyagishima; Nami Mori; Hitoshi Hishida
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

8.  Intravenous immunoglobulin in the therapy of adult acute fulminant myocarditis: A retrospective study.

Authors:  Dan-Qing Yu; Ying Wang; Gui-Zhou Ma; Rong-He Xu; Zhi-Xiong Cai; Chu-Min Ni; Ping Chen; Zhi-Dan Zhu
Journal:  Exp Ther Med       Date:  2013-10-29       Impact factor: 2.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.